Upgrade to SI Premium - Free Trial

Ipsen S.a. Sponsored Adr (IPSEY)

43.85 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Latest Headlines

National Survey From Ipsen Shows Young People Are Not Prepared for the Shift From Pediatric to Adult Healthcare May 20, 2026 7:15 AM - BizWire Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction May 16, 2026 8:00 AM - Globe NewsWire FDA: Alerts health care providers and patients about increased risk of new blood cancers with Tazverik (tazemetostat) use May 11, 2026 1:21 PM - StreetInsider Full Article List